PF-Atlas › Clinical Trials › NCT07933133

A Multicenter, Randomized, Blinded, Placebo- and Active-Controlled Phase II Study to Evaluate the Efficacy and Safety of SYH9061 in Adult Patients With Idiopathic Pulmonary Fibrosis

SYH9061 · Phase 2

Registry ID
NCT07933133
Phase
Phase 2
Status
Not yet recruiting
Drug / intervention
SYH9061
Sponsor
CSPC-NBP Pharmaceutical Co., Ltd.
Enrollment
300
Locations
1

About this trial

This is a multicenter, randomized, blinded, placebo- and active-controlled Phase II study to evaluate the efficacy, safety, and pharmacokinetic (PK) profile of SYH9061 at different doses and dosing frequencies in patients with IPF, and to determine the optimal recommended dose for Phase III confirmatory studies.

View NCT07933133 on ClinicalTrials.gov →

Medical disclaimer. This page summarizes public trial data for NCT07933133 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.